These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 3765524

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [The role of radiotherapy in the treatment of stage I-II Hodgkin's disease in children].
    Kanaev SV, Kolygin BA, Malinin AP, Chikrizov SI.
    Med Radiol (Mosk); 1986 Jul; 31(7):14-8. PubMed ID: 3755492
    [Abstract] [Full Text] [Related]

  • 4. [Role of radiotherapy in the treatment of stage IIIB Hodgkin's disease in children].
    Kanaev SV, Kolygin BA, Malinin AP, Chikrizov SI.
    Med Radiol (Mosk); 1987 May; 32(5):13-5. PubMed ID: 3586916
    [Abstract] [Full Text] [Related]

  • 5. Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute.
    Petera J, Macharová H, Pohanková R, Malír A, Coupek P, Konecný M, Patera J, Pecina J, Drbal J, Koukalová H, Vásová I.
    Neoplasma; 2000 May; 47(2):129-32. PubMed ID: 10985481
    [Abstract] [Full Text] [Related]

  • 6. [Hodgkin's disease in children; treatment results with or without radiotherapy].
    Behrendt H.
    Ned Tijdschr Geneeskd; 1986 May 10; 130(19):865-8. PubMed ID: 3754935
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The use of combination chemotherapy in the treatment of early stage Hodgkin's disease.
    Longo DL, DeVita VT.
    Important Adv Oncol; 1992 May 10; ():155-65. PubMed ID: 1582671
    [No Abstract] [Full Text] [Related]

  • 9. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I, Ganser D, Freitag EM, Bohndorf W.
    Strahlenther Onkol; 1994 Sep 10; 170(9):516-23. PubMed ID: 7524173
    [Abstract] [Full Text] [Related]

  • 10. [Evaluation of the effectiveness of chemoradiotherapy of stage IIIA Hodgkin's disease].
    Kanaev SV, Gershanovich ML, Malinin AP, Kholin AV.
    Med Radiol (Mosk); 1987 May 10; 32(5):16-21. PubMed ID: 3586917
    [Abstract] [Full Text] [Related]

  • 11. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
    Tan WY, Hu DS, Zeng FY, Song QB, Hu S, Wei L, Zhou LQ.
    Ai Zheng; 2007 Dec 10; 26(12):1360-4. PubMed ID: 18076802
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.
    Noordijk EM, Carde P, Dupouy N, Hagenbeek A, Krol AD, Kluin-Nelemans JC, Tirelli U, Monconduit M, Thomas J, Eghbali H, Aleman BM, Bosq J, Vovk M, Verschueren TA, Pény AM, Girinsky T, Raemaekers JM, Henry-Amar M.
    J Clin Oncol; 2006 Jul 01; 24(19):3128-35. PubMed ID: 16754934
    [Abstract] [Full Text] [Related]

  • 14. [Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease].
    Wang WH, Li YX, Song YW, Jin J, Liu YP, Wang SL, Zhou LQ, Liu XF, Yu ZH, Han JZ.
    Zhonghua Zhong Liu Za Zhi; 2006 Mar 01; 28(3):218-21. PubMed ID: 16875611
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of Hodgkin's disease including the staging laparotomy].
    Yosida T, Nakanisi J, Kobayasi S, Ohtake S, Ito K, Nakamura S, Hattori K, Saito Y, Tanimoto K.
    Rinsho Ketsueki; 1984 Jun 01; 25(6):827-34. PubMed ID: 6548266
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Significance of procarbazine in the chemotherapy of Hodgkin's disease--a report of the Cooperative Therapy Study DAL-HD-85].
    Schellong G, Hörnig I, Brämswig J, Bökkerink JP, Steinhoff A, Ludwig R, Niethammer D, Reiter A, von Lengerke HJ, Heinecke H.
    Klin Padiatr; 1988 Jun 01; 200(3):205-13. PubMed ID: 3062257
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease.
    Hudson MM, Krasin M, Link MP, Donaldson SS, Billups C, Merchant TE, Kun L, Billet AL, Kaste S, Tarbell NJ, Howard S, Friedmann AM, Hurwitz CA, Young JA, Marcus KC, Rai S, Cowan T, Weinstein HJ.
    J Clin Oncol; 2004 Nov 15; 22(22):4541-50. PubMed ID: 15542805
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.